Abbvie Inc (NYSE:ABBV)
| 85.19 Delayed Data As of Oct 30 |  +4.52 / +5.60%Today’s Change | 62.55 Today|||52-Week Range 101.28 | -3.78% Year-to-Date |
Latest ABBV News | Press Releases
| Is Drug Pricing Backlash a Serious Risk for Big Pharma Stocks? 8:22am / MotleyFool.com - Paid Partner Content | Friday Morning Market Highlights Oct 30 / GuruFocus News - Paid Partner Content |
| 5 No-Brainer Stocks to Buy if Donald Trump Wins in November 6:40am / MotleyFool.com - Paid Partner Content | AbbVie (ABBV) Q3 Earnings and Revenues Top Estimates Oct 30 / Zacks.com - Paid Partner Content |
| AbbVie (ABBV) Q3 2020 Earnings Call Transcript 6:01am / MotleyFool.com - Paid Partner Content | 2 No-Brainer Dividend Stocks Yielding More Than 4% Oct 30 / MotleyFool.com - Paid Partner Content |
| How AbbVie Beat Expectations in Q3 Oct 30 / MotleyFool.com - Paid Partner Content | Amgen (AMGN) Q3 Earnings Top, Prolia, Biosimilars Drive Sales Oct 29 / Zacks.com - Paid Partner Content |
| AbbVie (ABBV) Beats on Q3 Earnings & Sales, Ups 2020 Guidance Oct 30 / Zacks.com - Paid Partner Content | 2 Healthcare Dividend Stocks to Buy No Matter Who Wins the Election Oct 29 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 80.67 |
| Today’s open | 83.39 |
| Day’s range | 83.39 - 86.13 |
| Volume | 18,095,146 |
| Average volume (3 months) | 7,250,863 |
| Market cap | $142.1B |
Data as of 4:27pm ET, 10/30/2020
Growth & Valuation
| Earnings growth (last year) | +44.28% |
| Earnings growth (this year) | +16.60% |
| Earnings growth (next 5 years) | +6.31% |
| Revenue growth (last year) | +1.57% |
| P/E ratio | 18.6 |
| Price/Sales | 3.95 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.91 | -1.78% |
| BMYBristol-Myers Squibb | +0.55 | +0.95% |
| LLYEli Lilly and Co | -2.15 | -1.62% |
| NVONovo Nordisk | -2.53 | -3.81% |
Data as of 7:56pm ET, 10/30/2020
Financials
| Next reporting date | January 22, 2021 |
| EPS forecast (this quarter) | $2.90 |
| Annual revenue (last year) | $33.3B |
| Annual profit (last year) | $7.8B |
| Net profit margin | 23.57% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
